GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alar Pharmaceuticals Inc (ROCO:6785) » Definitions » Price-to-Funds-From-Operations

Alar Pharmaceuticals (ROCO:6785) Price-to-Funds-From-Operations : (As of Dec. 13, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Alar Pharmaceuticals Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Alar Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
No. 19, Keyuan Road, Rm. 312, 3rd Floor, Xitun District, Taichung, TWN, 407
Alar Pharmaceuticals Inc is a drug development company. It focuses on developing long-acting release drug products for CNS disorders and chronic diseases, which mainly include opioid use disorder, chronic pain, and major depressive disorder. These chronic diseases not only cause long-term burdens to the patients and their families but also consume huge social costs.